p 138: improving neuroplasticity through neuroinflammation pathways as a therapeutic goal in the treatment of autism

Authors

niloofar rambod rad islamic azad university, mashhad branch, mashhad, iran

alma miraghel islamic azad university, mashhad branch, mashhad, iran

mohammad reza khojaste islamic azad university, mashhad branch, mashhad, iran

abstract

neuroplasticity is the brain's ability to reorganize itself by forming new neural connections throughout life. neuroplasticity allows the neurons in the brain to compensate injury and disease and to adjust their activities in response to new situations or to changes in their environment. at the other side, it is now well established that neuronal function is strongly influenced by both central and peripheral inflammation and it is able to modulate the efficacy of synaptic transmission and the induction of the main forms of synaptic plasticity. astrocytes, glial and microglial cells are recognized as active elements of synapses, playing a central role in neuro-inflammatory processes. this feature can be used as therapeutic goal in many brain diseases such as multiple sclerosis, alzheimer, epilepsy, parkinson's disease, autism spectrum disorder, etc. autism, or autism spectrum disorder (asd), refers to a range of conditions characterized by challenges with social skills, repetitive behaviors, speech and nonverbal communication, as well as by unique strengths and differences. newly, some studies suggested that an abnormal function of glia and astrocytes may be involved in the development of autism. recent studies reported some markers that are effect asd mechanism including glial fibrillary acidic protein (gfap), aquaporin4, connexin43, methyl-cpg-binding protein 2 (mecp2) and etc. the present review summarizes the latest understanding of novel asd treatment that effect neuron plasticity, especially proteins and cytokines that are involved in neuro-inflammation pathways and the process that damages neuroplasticity. however, there is yet no direct evidence showing how neuro-inflammation pathways can improve neuroplasticity in the brain of autistic patient and improve the life of these patients. this review indicates more research is essential to study on these markers as a therapeutic goal in the treatment of autism.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

P 138: Improving Neuroplasticity Through Neuroinflammation Pathways as a Therapeutic Goal in the Treatment of Autism

Neuroplasticity is the brain's ability to reorganize itself by forming new neural connections throughout life. Neuroplasticity allows the neurons in the brain to compensate injury and disease and to adjust their activities in response to new situations or to changes in their environment. At the other side, it is now well established that neuronal function is strongly influenced by both central ...

full text

P 115: Potential Therapeutic Targets Related to Neuroinflammation in Treatment and Prevention of Autism

Autism spectrum disorder (ASD) is a mental condition, present from early childhood, characterized by great difficulty in communicating and forming relationships with others and using language. In the last four decades many studies have shown that immune responses in different regions of brain play an important role in ASD pathogenicity. A conservative estimate based on the research suggests tha...

full text

P 60: The Effect of Melatonin as a Therapeutic Goal on Multiple Sclerosis Through Immune Processes

Multiple sclerosis is an autoimmune disease of the central nervous system which is accompanied by demyelinating the neurons. The imbalance between the T cell effectors and T cell regulators is thought to have a role in the pathogenesis of the disease. Melatonin is a hormone that is secreted by pineal gland which has an important role in circadian rhythm and immune-modulatory effects. Melatonin ...

full text

p 60: the effect of melatonin as a therapeutic goal on multiple sclerosis through immune processes

multiple sclerosis is an autoimmune disease of the central nervous system which is accompanied by demyelinating the neurons. the imbalance between the t cell effectors and t cell regulators is thought to have a role in the pathogenesis of the disease. melatonin is a hormone that is secreted by pineal gland which has an important role in circadian rhythm and immune-modulatory effects. melatonin ...

full text

p 115: potential therapeutic targets related to neuroinflammation in treatment and prevention of autism

autism spectrum disorder (asd) is a mental condition, present from early childhood, characterized by great difficulty in communicating and forming relationships with others and using language. in the last four decades many studies have shown that immune responses in different regions of brain play an important role in asd pathogenicity. a conservative estimate based on the research suggests tha...

full text

P 61: MicroRNA as a Therapeutic Tool to Prevent Blood Brain Barrier Dysfunction in Neuroinflammation

Endothelial cells present in brain are unique and differ from other peripheral tissues in a number of ways, which ensures specific brain endothelial barrier properties. Endothelial dysfunction is the earliest event in the initiation of vascular damage caused by inflammation. Various microRNAs (miRNA) have been discovered in different cellular components of the blood bran barrier (BBB). miRNAs a...

full text

My Resources

Save resource for easier access later


Journal title:
مجله علوم اعصاب شفای خاتم

جلد ۵، شماره ۲، صفحات ۱۶۹-۱۶۹

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023